| Literature DB >> 30107265 |
Tao Zhang1, Caterina De Carolis2, Gene Chi Wai Man3, Chi Chiu Wang4.
Abstract
Endometriosis (EMS), an estrogen-dependent inflammatory disorder affects approximately 5-10% of the general female population of reproductive age and 20-90% of women with pelvic pain and infertility. Many immunological factors are known to contribute significantly to the pathogenesis and pathophysiology of EMS, and both chronic local inflammation and autoantibodies in EMS shares many similarities with autoimmune diseases (AD). However, the autoimmune etiology in EMS remains controversial, and its evidence on autoimmune basis may be limited. Here we aim to review the current understanding between autoimmunity and EMS to provide important knowledge to develop future potential immunomodulatory therapy for the treatment of EMS.Entities:
Keywords: Autoantibodies; Autoimmune disease (AD); Complement (C); Cytokines; Endometriosis (EMS); Immune escape; Immunomodulators
Mesh:
Substances:
Year: 2018 PMID: 30107265 DOI: 10.1016/j.autrev.2018.03.017
Source DB: PubMed Journal: Autoimmun Rev ISSN: 1568-9972 Impact factor: 9.754